Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial

A Lanas, JA Baron, RS Sandler, K Horgan… - Gastroenterology, 2007 - Elsevier
Background & Aims: Our aim was to establish the incidence of symptomatic upper
gastrointestinal ulcers, ulcer perforation, ulcer obstruction, or bleeding episodes (PUBs) …
被引用次数：91 相关文章

Peptic Ulcer and Bleeding Events Associated With Rofecoxib in a 3-Year Colorectal Adenoma Chemoprevention Trial

A Lanas, JA Baron, RS Sandler, K Horgan… - BMC …, 2007 - cdr.lib.unc.edu
BACKGROUND & AIMS: Our aim was to establish the incidence of symptomatic upper
gastrointestinal ulcers, ulcer perforation, ulcer obstruction, or bleeding episodes (PUBs) …

Peptic Ulcer and Bleeding Events Associated With Rofecoxib in a 3-Year Colorectal Adenoma Chemoprevention Trial

A Lanas, JA Baron, RS Sandler… - …, 2007 - mdanderson.elsevierpure.com
Background & Aims: Our aim was to establish the incidence of symptomatic upper
gastrointestinal ulcers, ulcer perforation, ulcer obstruction, or bleeding episodes (PUBs) …

Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial.

A Lanas, JA Baron, RS Sandler, K Horgan… - 2007 - cabidigitallibrary.org
Abstract Background and Aims: Our aim was to establish the incidence of symptomatic
upper gastrointestinal ulcers, ulcer perforation, ulcer obstruction, or bleeding episodes …

Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial.

A Lanas, JA Baron, RS Sandler, K Horgan… - …, 2006 - europepmc.org
Methods A total of 2587 patients with a history of colorectal adenomas underwent
randomization to 25 mg/day of rofecoxib or to placebo. Investigator-reported PUBs were …

Peptic Ulcer and Bleeding Events Associated With Rofecoxib in a 3-Year Colorectal Adenoma Chemoprevention Trial

A Lanas, JA Baron, RS Sandler, K Horgan… - …, 2007 - gastrojournal.org
Background & Aims: Our aim was to establish the incidence of symptomatic upper
gastrointestinal ulcers, ulcer perforation, ulcer obstruction, or bleeding episodes (PUBs) …

Peptic Ulcer and Bleeding Events Associated With Rofecoxib in a 3-Year Colorectal Adenoma Chemoprevention Trial

A Lanas, JA Baron, RS Sandler, K Horgan… - Gastroenterology, 2007 - infona.pl
Background & Aims: Our aim was to establish the incidence of symptomatic upper
gastrointestinal ulcers, ulcer perforation, ulcer obstruction, or bleeding episodes (PUBs) …

Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial

A Lanas, JA Baron, RS Sandler, K Horgan… - 2007 - pubmed.ncbi.nlm.nih.gov
Background & aims Our aim was to establish the incidence of symptomatic upper
gastrointestinal ulcers, ulcer perforation, ulcer obstruction, or bleeding episodes (PUBs) …

Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial

A Lanas, JA Baron, RS Sandler… - …, 2007 - research.birmingham.ac.uk
BACKGROUND & AIMS: Our aim was to establish the incidence of symptomatic upper
gastrointestinal ulcers, ulcer perforation, ulcer obstruction, or bleeding episodes (PUBs) …

Peptic Ulcer and Bleeding Events Associated With Rofecoxib in a 3-Year Colorectal Adenoma Chemoprevention Trial

A Lanas, JA Baron, RS Sandler, K Horgan… - Gastroenterology, 2007 - infona.pl
Background & Aims: Our aim was to establish the incidence of symptomatic upper
gastrointestinal ulcers, ulcer perforation, ulcer obstruction, or bleeding episodes (PUBs) …